AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print Apr 26, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2005.083253v1
97/6/974    most recent
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Myung, P.
Right arrow Articles by Tucker, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Myung, P.
Right arrow Articles by Tucker, J.
©
American Journal of Public Health, 10.2105/AJPH.2005.083253


Field Action Reports

Directly Observed Highly Active Antiretroviral Therapy for HIV-Infected Children in Cambodia

Patricia Myung 1, David Pugatch 2*, Mark F. Brady 3, Phok Many 4, Joseph I. Harwell 5, Mark Lurie 3, John Tucker 4

1 University of California at Irvine
2 Rhode Island Hospital
3 Brown Medical School
4 Maryknoll Little Sprouts Program
5 The Miriam Hospital

* To whom correspondence should be addressed. E-mail: dpugatch{at}lifespan.org.


   Abstract

Antiretroviral medications are becoming available for HIV-infected children in resource-limited settings. Maryknoll, an international Catholic charity, provided directly observed antiretroviral therapy to HIV-infected children in Phnom Penh, Cambodia. Child care workers administered generic antiretroviral drugs twice daily to children, ensuring adherence.

Treatment began with 117 late-stage HIV-infected children; 22 died of AIDS during the first 6 months. The rest were treated for at least 6 months and showed CD4 count increases comparable to those achieved in US and European children. Staffing cost for this program was approximately US $5 per child per month, or 15% more than the price of the medications. Drug toxicities were uncommon and easily managed.

Directly observed antiretroviral therapy appears to be a promising, low-cost strategy for ensuring adherent treatment for HIV-infected children in a resource-limited setting.

Key Words: Community Health, Global Health, Health Care Facilities/Services, HIV/AIDS







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Public Health Association